Epilepsia Partialis Continua: Clinical Trials

3 trials for Epilepsia Partialis Continua, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

3 terminated. 2 Not applicable, 1 Phase 3.

By phase and status

PhaseTrialsStatus
Not applicable2Terminated 2
Phase 31Terminated 1

Follow Epilepsia Partialis Continua: new trials by email Literature Review of Epilepsia Partialis Continua trials Research Report on Epilepsia Partialis Continua

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Repeated TMS at Low Frequencies to Reduce Seizure Occurrence
Low frequency repeated TMS (LF-rTMS) - Epilepsy, Status Epilepticus
Not applicableTerminatedBaptist Health South Florida22016-02-192023-06-23
Repetitive Transcranial Magnetic Stimulation (rTMS) for the Treatment of Epilepsy
repetitive transcranial magnetic stimulation - Epilepsia Partialis Continua, Status Epilepticus
Not applicableTerminatedUniversity Hospital, Ghent42015-02-032022-02-15
Clobazam Use in Epilepsia Partialis Continua - Pilot Study
Clobazam, Clonazepam, Lorazepam - Epilepsia Partialis Continua, Kojewnikov's Epilepsy
Phase 3TerminatedThe Cooper Health System72014-07-012018-05-09

Narrower conditions

Epilepsy (3)  ·  Status Epilepticus (2)  ·  Epilepsy, Partial, Motor (1)

Broader conditions

Brain Diseases (3)  ·  Central Nervous System Diseases (3)  ·  Nervous System Diseases (3)  ·  Neurologic Manifestations (3)  ·  Pathological Conditions, Signs and Symptoms (3)  ·  Seizures (3)  ·  Signs and Symptoms (3)  ·  Epilepsies, Partial (1)  ·  Status Epilepticus (1)

Interventions

Clobazam (1)  ·  Clonazepam (1)  ·  Lorazepam (1)  ·  Transcranial Magnetic Stimulation (1)

Sponsors

Baptist Health South Florida (1)  ·  The Cooper Health System (1)  ·  University Hospital, Ghent (1)

Countries

United States (2)  ·  Belgium (1)

Top investigators

Alberto Pinzon, M.D., Ph.D. (1)  ·  Alfred Meurs, MD, PhD (1)  ·  Melissa Carran, MD (1)